Abstract, Snapshot, Market Analysis & Market Definition: Pruritus Therapeutics Market
Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex. Skin disease is the fourth leading cause of nonfatal disease burden. Skin diseases include eczema, psoriasis, acne vulgaris, pruritus, alopecia areata, decubitus ulcer, urticaria, scabies, fungal skin diseases, impetigo, abscess, and other bacterial skin diseases, cellulitis, viral warts, molluscum contagiosum, and non-melanoma skin cancer. Among these types, fungal skin diseases and pruritus were in the top 10 most prevalent diseases worldwide in 2010. Thus pruritus therapeutics market is growing with rising prevalence of skin diseases. Moreover, patent expiration of dermatitis drugs and the introduction of new products are also responsible for the growth of pruritus therapeutics market. In 2018, the global Pruritus Therapeutics market size was 11870 million US$ and it is expected to reach 16700 million US$ by the end of 2025, with a CAGR of 5.0% during 2019-2025. This report focuses on the global Pruritus Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pruritus Therapeutics development in United States, Europe and China.
Market Segmentation, Outlook & Regional Insights: Pruritus Therapeutics Market
Segmentation by Product Type: Breakdown of data from year 2014 to 2019 and forecast until 2025:
Antihistamines
Corticosteroids
Calcineurin Inhibitors
Other
Segmentation by Application : Breakdown of data from year 2014 to 2019 and forecast until 2025:
External Use
Oral
Injection
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
Key Players, Recent Developments & Sector Viewpoints: Pruritus Therapeutics Market
J&J
Abbott
Amgen
LEO Pharma
Novartis
Bayer
Pfizer
UCB Pharma
GlaxoSmithKline
Galderma
Huapont
Key Industry Development
In Aug 2020
, LEO Pharma A/S announced the sale of a portfolio of four non-core products to Cheplapharm for EUR 300 million. The agreement represents a milestone in the roll-out of LEO Pharma’s 2030 strategy which increases the company’s focus on new innovative solutions for medical dermatology.
The divested portfolio comprises four products within bone disorders/nephrology, dermatology and gynecology: One-Alpha©(Alfacalcidol), Locoid©(Cortisol), Pimafucin©(Natamycin), and Zineryt©(Erythromycin 40 mg and Zinc Acetate dihydrate). The annual turnover of the portfolio in 2019 amounted to approximately EUR 110 million.
The transaction is expected to close by December 2020, subject to satisfaction of customary closing conditions, including receipt of regulatory approvals. Following the closing, LEO Pharma and Cheplapharm will work closely together to ensure a smooth and effective transition of the products and business.
Key Insights Covered: Exhaustive Pruritus Therapeutics Market
1. Market size (sales, revenue and growth rate) of Pruritus Therapeutics industry.
2. Global major manufacturers' operating situation (sales, revenue, growth rate and gross margin) of Pruritus Therapeutics industry.
3. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Pruritus Therapeutics industry.
4. Market size (sales, revenue) forecast by regions and countries from 2019 to 2025 of Pruritus Therapeutics industry.
Research Methodology: Pruritus Therapeutics Market
- Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
- Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
- Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others.